Suppr超能文献

具有 HLA-DRB1*13 和 HLA-DQB1*06 等位基因的 HIV 控制器具有强大的、多功能的粘膜 CD4+ T 细胞反应。

HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.

机构信息

Department of Medical Microbiology and Immunology, School of Medicine, University of California, 3327 Tupper Hall, 1 Shields Ave., Davis, CA 95616, USA.

出版信息

J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18.

Abstract

A small percentage of human immunodeficiency virus (HIV)-infected individuals, termed elite controllers, are able to spontaneously control HIV replication in blood. As the gastrointestinal mucosa is an important site of HIV transmission and replication as well as CD4+ T-cell depletion, it is important to understand the nature of the immune responses occurring in this compartment. Although the role of the HIV-specific CD8+ T-cell responses in mucosal tissues has been described, few studies have investigated the role of mucosal HIV-specific CD4+ T cells. In this study, we assessed HIV-specific CD4+ T-cell responses in the rectal mucosa of 28 "controllers" (viral load [VL] of <2,000 copies/ml), 14 "noncontrollers" (VL of >10,000 copies/ml), and 10 individuals on highly active antiretroviral therapy (HAART) (VL of <75 copies/ml). Controllers had higher-magnitude Gag-specific mucosal CD4+ T-cell responses than individuals on HAART (P<0.05), as measured by their ability to produce gamma interferon (IFN-γ), interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-α), and macrophage inflammatory protein 1β (MIP-1β). The frequency of polyfunctional mucosal CD4+ T cells was also higher in controllers than in noncontrollers or individuals on HAART (P<0.05). Controllers with the strongest HIV-specific CD4+ T-cell responses possessed class II HLA alleles, HLA-DRB113 and/or HLA-DQB106, previously associated with a nonprogression phenotype. Strikingly, individuals with both HLA-DRB113 and HLA-DQB106 had highly polyfunctional mucosal CD4+ T cells compared to individuals with HLA-DQB1*06 alone or other class II alleles. The frequency of polyfunctional CD4+ T cells in rectal mucosa positively correlated with the magnitude of the mucosal CD8+ T-cell response (Spearman's r=0.43, P=0.005), suggesting that increased CD4+ T-cell "help" may be important in maintaining strong CD8+ T-cell responses in the gut of HIV controllers.

摘要

一小部分人类免疫缺陷病毒(HIV)感染者被称为精英控制器,他们能够自发地控制血液中的 HIV 复制。由于胃肠道黏膜是 HIV 传播和复制以及 CD4+T 细胞耗竭的重要部位,因此了解发生在该部位的免疫反应的性质非常重要。虽然已经描述了 HIV 特异性 CD8+T 细胞反应在黏膜组织中的作用,但很少有研究调查黏膜 HIV 特异性 CD4+T 细胞的作用。在这项研究中,我们评估了 28 名“控制器”(病毒载量[VL] <2000 拷贝/ml)、14 名“非控制器”(VL >10000 拷贝/ml)和 10 名接受高效抗逆转录病毒治疗(HAART)(VL <75 拷贝/ml)直肠黏膜中的 HIV 特异性 CD4+T 细胞反应。与接受 HAART 的个体相比(P<0.05),控制器具有更高幅度的 Gag 特异性黏膜 CD4+T 细胞反应,如通过其产生伽马干扰素(IFN-γ)、白细胞介素-2(IL-2)、肿瘤坏死因子 alpha(TNF-α)和巨噬细胞炎症蛋白 1β(MIP-1β)的能力来衡量。与非控制器或接受 HAART 的个体相比,控制器中多效性黏膜 CD4+T 细胞的频率也更高(P<0.05)。具有最强 HIV 特异性 CD4+T 细胞反应的控制器具有 II 类 HLA 等位基因 HLA-DRB113 和/或 HLA-DQB106,这些等位基因先前与非进展表型相关。引人注目的是,同时具有 HLA-DRB113 和 HLA-DQB106 的个体与仅具有 HLA-DQB1*06 或其他 II 类等位基因的个体相比,具有高度多效性的黏膜 CD4+T 细胞。直肠黏膜中多效性 CD4+T 细胞的频率与黏膜 CD8+T 细胞反应的幅度呈正相关(Spearman r=0.43,P=0.005),这表明增加 CD4+T 细胞“帮助”可能对维持 HIV 控制器肠道中强大的 CD8+T 细胞反应很重要。

相似文献

1
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18.
4
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
Blood. 2009 Apr 23;113(17):3978-89. doi: 10.1182/blood-2008-10-182709. Epub 2008 Dec 23.
7
Case report: mechanisms of HIV elite control in two African women.
BMC Infect Dis. 2018 Jan 25;18(1):54. doi: 10.1186/s12879-018-2961-8.
9
HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.
Clin Infect Dis. 2011 Mar 1;52(5):681-7. doi: 10.1093/cid/ciq202. Epub 2011 Jan 18.
10
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
AIDS Res Hum Retroviruses. 2016 Aug;32(8):791-800. doi: 10.1089/AID.2015.0313. Epub 2016 May 2.

引用本文的文献

2
Exceptional, naturally occurring HIV-1 control: Insight into a functional cure.
Med. 2024 Sep 13;5(9):1071-1082. doi: 10.1016/j.medj.2024.06.008. Epub 2024 Jul 15.
3
Multiparameter Flow Cytometry Monitoring of T Cell Responses.
Methods Mol Biol. 2024;2807:325-342. doi: 10.1007/978-1-0716-3862-0_22.
4
Inclusion body myositis, viral infections, and TDP-43: a narrative review.
Clin Exp Med. 2024 May 2;24(1):91. doi: 10.1007/s10238-024-01353-9.
5
Mucosal T-cell responses to chronic viral infections: Implications for vaccine design.
Cell Mol Immunol. 2024 Sep;21(9):982-998. doi: 10.1038/s41423-024-01140-2. Epub 2024 Mar 8.
8
Reduced CCR5 expression among Uganda HIV controllers.
Retrovirology. 2023 May 25;20(1):8. doi: 10.1186/s12977-023-00626-7.
9
Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial.
Front Med (Lausanne). 2022 Nov 14;9:1044713. doi: 10.3389/fmed.2022.1044713. eCollection 2022.

本文引用的文献

2
HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.
PLoS Pathog. 2010 Feb 26;6(2):e1000780. doi: 10.1371/journal.ppat.1000780.
4
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
Blood. 2009 Apr 23;113(17):3978-89. doi: 10.1182/blood-2008-10-182709. Epub 2008 Dec 23.
5
Quantifying HIV-1-specific CD8 (+) T-cell responses using ELISPOT and cytokine flow cytometry.
Methods Mol Biol. 2009;485:359-74. doi: 10.1007/978-1-59745-170-3_24.
6
Isolating mucosal lymphocytes from biopsy tissue for cellular immunology assays.
Methods Mol Biol. 2009;485:347-56. doi: 10.1007/978-1-59745-170-3_23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验